NASDAQ NMS - GLOBAL MARKET · ARAY
+4.74% · +$0.0120 · Vol 524.5K
After hours · updated 16:54:54 ET
Accuray Inc

Accuray Inc

Health Care
$0.2650

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is ARAY moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Accuray Inc
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed since
2007
Employees
990
Country
US

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.2600
Day high
$0.2641
Day low
$0.2501
Previous close
$0.2530
52W high
$0.3499
-24.26% from high
52W low
$0.2490
16% of range
Market cap
$30.1M
EPS
$-0.4000
Shares out
119M
Volume
524.5K
VWAP
$0.2566
Price history computed in-house
1W
+3.96%
1M
-20.18%
SMA 50 $0.3031 · below
SMA 200 $0.3031 · below
52W position 16%
Veridion warehouse edge

Warehouse intelligence for ARAY.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

ARAY insider activity

Accuray Inc

Score
Coverage building
Pressure
Net selling
Filings
12
Buys / sells
4 / 8
Net value
-$69K
Insiders
8
Named filers
CS
Chalke Sandeep
Insider
Leadership
PL
Peralta Leonel
Insider
Leadership
MF
MAYER STEVEN F
Insider
Leadership
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Net selling: -$69K across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-04-012026-03-31Chalke SandeepInsidersell$0.3940,000419,806$16KSEC Form 4
2026-03-032026-02-28Peralta LeonelInsidersell$0.5528,96954,754$16KSEC Form 4
2026-02-232026-02-20MAYER STEVEN FInsiderbuy$0.5654,8751,545,620$31KSEC Form 4
2026-02-202026-02-19MAYER STEVEN FInsiderbuy$0.5369,0001,490,745$37KSEC Form 4
2026-02-202026-02-18MAYER STEVEN FInsiderbuy$0.53126,1251,421,745$67KSEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 7 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

ARAY contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ARAY in this window.
Lobbying spend

ARAY lobbying filings, year to date.

Registered lobbying filings matched to Accuray Inc.

$160.0K
Refresh interval: 12hSource: LDA disclosure filings
Medicare/Medicaid Trade (domestic/foreign)
Filing
$40.0K
ACCURAY INCORPORATED

JEFFREY J. KIMBELL & ASSOCIATES, INC.

Apr 17, 2026
Filing
$40.0K
ACCURAY INCORPORATED

JEFFREY J. KIMBELL & ASSOCIATES, INC.

Mar 12, 2026
Filing
$40.0K
ACCURAY INCORPORATED

JEFFREY J. KIMBELL AND ASSOCIATES

Mar 9, 2026
Latest news · ARAY
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for ARAY.
Options
Sovereign unlock shows live options positioning for ARAY.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.